Major endoscopic ultrasound needle manufacturers are leveraging the demand for minimally invasive cytological and histological studies, to support demand in the port-pandemic period.
DUBAI, UAE / ACCESSWIRE / August 13, 2020 / The global endoscopic ultrasound needles market is likely to grow to a valuation of approximately US$405 Mn between 2017 and 2025. Endoscopic procedures are often associated with the spread of droplets, splashes, and secretions from patients, which makes the risk of virus transmission much higher. Consequently, with guidelines to postpone non-urgent endoscopic medical procedures the endoscopic ultrasound needle market is expected to witness a short-term slump in demand.
“Applications of endoscopic ultrasound needles including bronchial endoscopy and procedures in areas other than the gastrointestinal tract are expected to generate growth opportunities in the near future. Investments into research for potential new applications will aid market growth for years to come,” says the FMI study.
For more insights into the Market, Request a Sample of this Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-9247
Endoscopic Ultrasound Needles Market – Key Takeaways
- Endoscopic ultrasound aspiration needles are highly sought after owing to application in lung cancer and pleural effusions.
- Non-Hodgkin Lymphoma diagnosis applications generates significant revenue, with associated tech advancements in EUS needles.
- North America remains a key market for endoscopic ultrasound needles, supported by rising use of gastroenterology, pulmonology, and oncology procedures.
Endoscopic Ultrasound Needles Market – Key Driving Factors
- The widespread and expanding population of geriatrics, coupled with high numbers of gastrointestinal cancer cases, aid market growth.
- Applications in diagnosis of numerous chronic ailments in the pancreas, lungs, and gastrointestinal tracts generate key lucrative opportunities.
Endoscopic Ultrasound Needle Market – Key Constraints
- Shortage of adequately skilled healthcare professionals is a major challenge to adoption of endoscopic ultrasound needles.
- Endoscopic ultrasound needles pose a notable risk of infection, which hurts sales and use.
For information on the Research Approach used in the Report, Request Methodology@ https://www.futuremarketinsights.com/askus/rep-gb-9247
The Anticipated Impact of Coronavirus
The increased risk of covid-19 transmission through the endoscopic procedures is a key factor that is hindering the demand for endoscopic ultrasound needles through the crisis period. Postponed elective endoscopic procedures enforced through government lockdown guidelines will hamper short term market growth. On the other hand, recovery of the industry is likely to be strong as the pandemic subsides, and pending endoscopy procedures are performed towards 2021.
Major manufacturers in the endoscopic ultrasound needle market include but are not limited to CONMED Corp., Medtronic, Boston Scientific Corp., Medi-globe, Cook Medical, ACE Medical Devices Pvt. Ltd., and Olympus Corp.
Endoscopic ultrasound needle manufacturers have been found investing research efforts into product development and launch initiatives and into getting faster regulatory approvals for their offerings.
For instance, Olympus Corp. has announced that its EZ Shot 3 plus 25 G, single use endoscopic ultrasound needle has acquired FDA approval for aspiration and biopsy procedures. Similarly, Exact Imaging has received FDA approval for its new, Sterile Transperineal Needle Guide for micro-ultrasound systems. Further, Cook Medical has introduced the EchoTip ProCore endobronchial ultrasound needle, to extract histological samples from the pulmonary region.
Request a Discount for this Report@ https://www.futuremarketinsights.com/request-discount/rep-gb-9247
More About the Report
The FMI’s market research report offers detailed insights on endoscopic ultrasound needle market. The market is scrutinized on the basis of product type (fine aspiration needles and fine biopsy needles), end user (ambulatory surgical centers, specialty clinics, and hospitals), and application (enteral EUS needles and bronchial EUS needles), across six key regions (North America, Latin America, Europe, Japan, Asia Pacific, and Middle East and Africa).
Explore Extensive Coverage of FMI’s Healthcare, Pharmaceuticals, and Medical Devices Landscape
Clinical Trials Market: Find insights on the global clinical trials market with segment analysis, statistics, influencing factors, and business strategies for a 10-year projection period.
Injectable Drug Delivery Market: FMI’s report on the global injectable drug delivery market offers details on the market during 2018-2028. The study covers impacting forces, sources of revenue, market leaders, and market strategies.
Microfluidics Market: Get an in-depth analysis on the microfluidics market with insights on growth levers, opportunities, regulations, restraints, regional markets and market leaders between 2016 and 2026.
Expert analysis, actionable insights, and strategic recommendations of the veteran research team at FMI helps clients from across the globe with their unique business intelligence requirements. With a repository of over thousand reports and 1 million+ data points, the team has scrutinized the healthcare, pharmaceuticals, and medical devices sector across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services. Reach out to explore how we can help.
Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: email@example.com
For Media Enquiries: firstname.lastname@example.org
SOURCE: Future Market Insights
View source version on accesswire.com: